Study guide
6.3 Quality Control Plans & Audit Techniques (CoC Standard 6.1)
NCRA Oncology Data Specialist ODS-C
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: The ODS-C Exam, the Oncology Data Specialist Profession & Standard Setters
1.1 ODS Exam Structure, Timing, Scoring & 2026 Testing Windows 1.2 From CTR to ODS: The Credential, Eligibility Routes & the Registrar's Role 1.3 Standard-Setting Organizations & the Manuals They Publish
2 Chapter 2: Legal Framework, HIPAA & State Reporting Laws
2.1 HIPAA Privacy Rule & the Public Health Reporting Exception 2.2 HIPAA Security Rule, Safeguards & Breach Notification 2.3 State Mandatory Cancer Reporting Laws & Statutory Authority
3 Chapter 3: Confidentiality, Release of Information, Ethics & Credential Maintenance
3.1 Patient Confidentiality Protocols & Data Access Policies 3.2 Handling Subpoenas, Discovery & Registry Immunity Statutes 3.3 NCRA Code of Ethics & ODS Credential Maintenance
4 Chapter 4: Registry Organization, Staffing & Information Systems
4.1 Types of Cancer Registries, Their Functions & Registry Operating Protocols 4.2 Registry Staffing Formulas, Time Studies & Resource Allocation 4.3 Electronic Registry Systems, Security & Disaster Recovery Planning
5 Chapter 5: Cancer Committee, Cancer Conferences & Quality Improvement
5.1 The Cancer Committee: CoC Standards 2.1–2.4, the CLP & Annual Program Activities 5.2 Multidisciplinary Cancer Case Conferences (CoC Standard 2.5) 5.3 Quality Improvement Principles & CoC Chapter 7 (Standards 7.1–7.3)
6 Chapter 6: CoC Accreditation Standards, NCDB & Data Quality
6.1 CoC Accreditation: Standards Structure, Program Categories & Accreditation Awards 6.2 The National Cancer Database (NCDB), RCRS Submission & CoC Quality Measures 6.3 Quality Control Plans & Audit Techniques (CoC Standard 6.1)
7 Chapter 7: Surveillance Programs, NAACCR Standards, Epidemiology & Statistics
7.1 National Cancer Surveillance Programs: SEER & CDC NPCR 7.2 NAACCR Data Exchange Standards, XML Data Specifications & Registry Certification 7.3 Basic Cancer Epidemiology & Descriptive Statistics 7.4 Basic Statistics: Frequency Distributions, Central Tendency, Risk Ratios & Odds Ratios 7.5 Survival Analysis, Life Tables & Presentation of Registry Data
8 Chapter 8: Medical Terminology, Anatomy & Types of Cancer
8.1 Medical Terminology & Standard Abbreviations for Cancer Abstracting 8.2 Human Anatomy & Physiology for Registrars: Tissues, Organ Walls, Subsites & Lymphatic Drainage 8.3 Types & Characteristics of Cancer: Benign vs. Malignant, Tumor Families, Spread & Precursors
9 Chapter 9: Casefinding & Reportability
9.1 Principles of Casefinding & Facility Reference Dates 9.2 Casefinding Sources: Pathology, Cytology, Disease Index & Logs 9.3 Reportability: What CoC, SEER and NPCR Require, Including Non-Malignant CNS Tumors 9.4 Ambiguous Terminology: Reportable Terms, Cytology, Discrepancies & "References of Last Resort"
10 Chapter 10: Diagnostic Procedures, Pathology Reporting, Lab Methods & Prognostic Indicators
10.1 Diagnostic & Staging Procedures: Imaging, Endoscopy, Biopsy & How They Are Coded 10.2 Pathology Reporting, CAP Cancer Protocols & Electronic Pathology (CoC Standard 5.1) 10.3 Specialty Laboratory Testing Methods: IHC, FISH, PCR/RT-PCR, NGS, Flow Cytometry & Cytogenetics 10.4 Prognostic Indicators & Site-Specific Data Items (SSDIs): HPV, KRAS, HER2 and More
11 Chapter 11: Class of Case, Key Dates & Case Identifiers
11.1 Class of Case, Date of First Contact, Date of Diagnosis & Accession/Sequence Numbers 11.2 Analytic Classes of Case (00, 10–14, 20–22): Definitions & Decision Rules 11.3 Nonanalytic Classes of Case (30–49, 99) & Why Central Registries Need Them
12 Chapter 12: Follow-Up, Vital Status & Recurrence
12.1 Follow-Up Purpose, Active & Passive Methods, and Follow-Up Source Codes 12.2 CoC Standard 6.5 Follow-Up Rates: Windows, Exclusions & Calculations 12.3 Vital Status, Date of Last Contact, Cancer Status & Death Clearance 12.4 Recurrence: Type of First Recurrence [1880], Date of First Recurrence [1860] & Recurrence vs. New Primary
13 Chapter 13: Abstracting, ICD-O-3.2 Site & Histology Coding, and Grade
13.1 The Abstracting Process: Workflow, Source Documents, Timeliness & Text Documentation 13.2 ICD-O-3.2 Topography, Primary Site Rules & Laterality 13.3 ICD-O-3.2 Morphology: Histology, Behavior & the Solid Tumor Histology Rules 13.4 Grade: The Four Time-Specific Grade Items & Site-Specific Grade Tables
14 Chapter 14: Solid Tumor Rules & Hematopoietic Coding Rules
14.1 Solid Tumor Rules: Purpose, Site Groups, Navigation & Timing Principles 14.2 Solid Tumor Rules for Breast, Colon/Rectum & Lung: The Multiple Primary Rules in Order 14.3 Solid Tumor Rules for Head & Neck, Kidney, Urinary, CNS, Melanoma & Other Sites 14.4 Hematopoietic & Lymphoid Neoplasms: Heme Manual, Heme DB, Multiple Primary & Primary Site Rules
15 Chapter 15: Staging: AJCC TNM (8th Edition & Version 9 Lung) and Summary Stage 2018
15.1 AJCC TNM Principles: Categories, Prefixes, Suffixes, General Rules & Registry Items 15.2 AJCC Time Frames: Clinical, Pathological, Post-Therapy (yc, yp), Recurrence & Autopsy 15.3 Breast Staging (AJCC 8th Edition, Part XI): T, N, M, Anatomic & Prognostic Stage Groups 15.4 Lung Staging (AJCC Version 9, 2025+): T, N2a/N2b, M1c1/M1c2 & New Stage Groups 15.5 Male Genital & Urinary Tract Staging (AJCC 8th Parts XIII–XIV): Prostate, Testis, Kidney, Bladder, Renal Pelvis & Ureter 15.6 SEER Summary Stage 2018: Codes, Timing, General Rules & Site Examples
16 Chapter 16: First-Course Treatment Coding (STORE 2025) & EDITS
16.1 Treatment Types, First Course of Treatment & Evidence-Based Guidelines (NCCN) 16.2 Surgery Coding: Rx Summ–Surg 2023 [1291], Lymph Node Surgery [1292], Other Site [1294], Margins & Reason for No Surgery 16.3 Radiation, Systemic, Transplant, Other & Palliative Treatment Coding (STORE 2025) 16.4 NAACCR EDITS, Over-ride Flags & Data Validation
6.3 Quality Control Plans & Audit Techniques (CoC Standard 6.1)
Key Takeaways Explain This Topic AI
The Standard 6.1 protocol sets review criteria, a timetable, methods, sources, reviewers, benchmarks, and how quality control activity and conflict resolution are documented.
Casefinding, abstracting timeliness and the percentage of items coded unknown are evaluated for all cases each year.
Accuracy review covers at least 10% of the annual analytic caseload, up to 200 cases, for class of case, primary site, histology, grade, AJCC or other stage, first-course treatment and four recurrence/cancer status items.
Reviewers may be ODSs, advanced practice nurses, physician assistants, physicians, fellows or residents, but an ODS may not review their own cases.
The program sets its own benchmarks; the audit results, recommendations and outcomes must be presented to the cancer committee in the same calendar year and recorded in the minutes.
Last updated: September 2026
Quality control versus quality improvement
Quality control (QC) checks the data : are cases complete, timely and correctly coded? Quality improvement (Section 5.3) uses the data to improve care . The exam tests both, and Domain 2 lists "quality control plan elements, activities, and methods" and "casefinding and quality assurance audit techniques" as separate topics. Registry QC for CoC-accredited programs is governed by Standard 6.1, Cancer Registry Quality Control .
Standard 6.1: the quality control protocol
Each calendar year the cancer committee implements a protocol to evaluate the quality of registry data and activity. The Cancer Registry Quality Coordinator , working with registry staff and other departments, carries it out, recommends corrective action when an area falls below the protocol's measures, and presents the results to the committee.
- Protocol element What it specifies
- A. Review criteria What counts as an error and how discrepancies are resolved
- B. Timetable When each QC activity happens during the year
C. Methods, sources and individuals Random sampling of the annual analytic caseload; review by designated people (ODSs, advanced practice registered nurses, physician assistants, physicians, fellows or residents), with ODSs never reviewing their own cases ; external audits, such as state or central registry casefinding audits, may fulfill part of the requirement
D. Activities evaluated for all cases each year 1. Casefinding; 2. Abstracting timeliness; 3. The percentage of information coded as unknown (usually 9 or a string of 9s)
E. Accuracy review of abstracted data A minimum of 10% of the annual analytic caseload, up to 200 cases , for: 1. Class of case; 2. Primary site; 3. Histology; 4. Grade; 5. AJCC stage or another appropriate staging system; 6. First course of treatment; 7. Follow-up items: date of first recurrence, type of first recurrence, cancer status, and date of last cancer status
F. Benchmarks The minimum quality benchmarks and required accuracy, plus the requirement that data submitted to the NCDB meet its quality and timeliness criteria
G. Documentation Review criteria, cases reviewed, errors found and their resolutions, and the percentage of accuracy for the items in D and E, reported to the committee each year
Reporting rules: the results, recommendations and outcomes of recommendations are presented to the cancer committee during the current calendar year and recorded in the minutes. The protocol, including the process for resolving conflicts found in review, is submitted with the Pre-Review Questionnaire. Patient data reviewed under Standard 6.1 cannot be reused as the physician's in-depth study for Standard 7.2.
Worked example: sample size
- Annual analytic caseload 10% Minimum accuracy review
- 450 45 45 cases
- 1,600 160 160 cases
- 2,000 200 200 cases
- 4,200 420 200 cases (the cap)
- Casefinding audits (completeness)
A casefinding audit checks whether every reportable case was found.
Choose independent sources , such as the pathology log, HIM disease index (ICD-10-CM codes), radiation oncology and infusion logs, and outpatient procedure logs, for a defined period.
Match each reportable case from those sources against the registry accession list and suspense file.
Investigate every miss. Was it truly reportable? Was the source screened? Was the case wrongly ruled out?
Calculate completeness: cases found in the registry ÷ reportable cases found in the audit sources × 100.
Fix the process , not only the missing cases. Add a source, change the ICD-10-CM code list, or retrain staff.
Central registries run the same kind of audit at facilities, and NPCR and SEER measure a central registry's completeness against expected counts. A state casefinding audit of the hospital can count toward part of the hospital's Standard 6.1 requirement.
Timeliness monitoring
CoC leaves the timeliness benchmark to the program's protocol, alongside the real deadlines: monthly RCRS submission (Standard 6.4) and the state reporting deadline . STORE's Date Case Completed – CoC [2092] is auto-calculated when the required items pass the "CoC Required – All" edit set, and STORE says it may be used for timeliness under Standard 6.1. Typical measures include the percentage of cases abstracted within the protocol's target interval from Date of First Contact, and an aging report of cases in suspense.
Accuracy (reabstracting) audits
Technique How it works Strength
Reabstracting audit A second qualified reviewer abstracts the case again from the source documents without seeing the original codes, then compares Most rigorous estimate of coding accuracy
Visual editing (text-to-code review) The reviewer checks whether each code is supported by the abstract's text fields and source documents Fast; catches unsupported codes
Recoding audit Reviewers code from a standardized set of records or text to test agreement between coders Measures reliability between staff
Computerized edits EDITS metafiles test code validity and logical consistency (Section 16.4) Covers 100% of cases, but cannot detect a valid code that is wrong
Targeted review Deliberately selects high-risk cases, such as new staff, new rules, complex sites or recent standard changes Finds known weak spots, but does not estimate the overall error rate
Standard 6.1 requires random sampling for the accuracy review. Programs may add targeted reviews on top of it.
Measuring accuracy
Item accuracy = items coded correctly ÷ items reviewed × 100. For example, 25 cases × 10 items = 250 items. If 6 are wrong, accuracy is 244/250 = 97.6% .
Case-level accuracy = cases with no errors ÷ cases reviewed. Some programs classify errors as major , where the error changes stage, primary site, histology or treatment category, or minor , and set separate benchmarks.
Unknown-value rate = cases with an item coded unknown ÷ cases × 100, tracked for key items such as stage and treatment.
Closing the loop
For each QC finding: correct the records (and resubmit them to RCRS and the state), look for the cause, retrain or change procedures, re-audit the affected area, and report the results, recommendations and outcomes to the committee in the same year.